Current estimations indicate that the global HLA typing market is valued at USD 1.1 billion. The market is expected to grow at a modest rate of 6.7% between 2023 and 2033. By 2033, the market valuation is projected to reach USD 2.1 billion.
Key Market Highlights
The Rising Amount of Transplant Treatments Boosts Demand for The HLA Typing Market
The global HLA typing market is expected to experience growth due to the rise in organ transplants, the increasing prevalence of chronic and infectious diseases, and advancements in the molecular assays used for HLA typing. The availability of funding for HLA typing research is another factor likely to impact the market positively. Additionally, increasing public awareness regarding organ donations presents an opportunity for the HLA typing market to expand.
| Attributes | Key Statistics |
|---|---|
| Expected Base Year Value (2023) | USD 1.1 billion |
| Anticipated Forecast Value (2033) | USD 2.1 billion |
| Estimated Growth (2023 to 2033) | 6.7% CAGR |
Despite the importance of molecular assays in HLA typing, their high costs remain a significant challenge for the HLA typing market. Additionally, the gap between the number of organs required for transplantation and the number of available organ donations presents a substantial obstacle for the HLA typing market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The diagnostic techniques for HLA typing have shifted from serology-based to genome-based procedures due to the development of PCR-based genome sequencing that is now integrated with microfluidics, biomedical instrumentation, and robotics.
The ongoing technological advancements in HLA typing have led to higher sample throughput, increased device sensitivity, early detection of incompatibility, and improved procedural efficacy compared to serological techniques. As a result of these benefits, the demand for HLA typing products has increased among significant end users such as research laboratories, hospitals, transplant centers, and diagnostic laboratories.
Several market players have expanded and commercialized PCR and NGS-based HLA typing reagents for detecting genetic modifications and determining precise HLA alleles. Efforts by the market players to boost the healthcare industry, coupled with rising disposable incomes worldwide, have also contributed to the industry's growth.
The need for transplantation procedures has proliferated in recent years, particularly for diseases like blood cancers and genetic blood disorders that require stem cell transplantation. Increased public awareness of organ transplantation and supportive regulations from regulatory authorities have further propelled the market forward.
As the number of transplant procedures continues to rise worldwide, the market is expected to experience significant growth in the forecasted period.
Several hospitals and market players are focusing on developing health infrastructure to reduce disease burden and improve healthcare services. Additionally, the increasing adoption of advanced medical devices, transplant treatments, and other therapies is creating favorable growth opportunities for the market throughout the forecast period.
| Attributes | Key Statistics |
|---|---|
| Expected Base Year Value (2022) | USD 1.0 billion |
| Final Value (2033) | USD 2.1 billion |
| Estimated Growth (2018 to 2022) | 8.2% CAGR |
Principal Consultant
The global HLA typing market has three categories based on the type of products - instruments, reagents and consumables, and software and services. The instruments segment is perfect for organ transplantation procedures of the vital organs.
The instruments segment held a CAGR of 8.0% from 2018 to 2022. The software and services segment is anticipated to catch up to the instruments segment in terms of value as organ transplantation, disease diagnosis, and personalized medicines expand during the research period. In the upcoming decade, the instruments segment has been supposed to dominate the market, according to a global CAGR of 6.5%.
| Top Product | Instruments |
|---|---|
| CAGR % 2018 to 2022 | 8.0% CAGR |
| CAGR % 2023 to End of Forecast (2033) | 6.5% CAGR |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
During the forecast period, the global HLA typing transplant market is segmented into diagnostics and research, with the diagnostics segment accounting for a leading market share in 2022, with a CAGR of 7.7%. This can be attributed to the trend among hospitals and transplant centers to outsource laboratory services, as well as the increase in diagnostics laboratories merging.
Hospitals and transplant centers collaborate with diagnostic labs to perform diagnostic tests that can diagnose diseases such as Behcet's disease, rheumatoid arthritis, and narcolepsy, which can accelerate the market for HLA typing. The research segment is expected to experience significant growth during the forecast period.
| Top Application | Diagnosis |
|---|---|
| CAGR % 2018 to 2022 | 7.7% CAGR |
| CAGR % 2023 to End of Forecast (2033) | 6.3% CAGR |
The HLA typing market in the United States generated revenue of USD 360.7 million in 2033. The market may grow significantly in the coming years, with an expected CAGR of 6.9% from 2023 to 2033. The United States dominates the market due to the rise in demand for organ transplants and the government's support to encourage growth in programs for organ donation and transplantation.
| Country | United States |
|---|---|
| CAGR (2018 to 2022) | 8.7% |
| CAGR (2023 to 2033) | 6.9% |
The United Kingdom is expected to dominate the market growth during the forecast period, thanks to the high adoption of advanced technologies and the increasing prevalence of the disease. These factors are expected to drive the development of the regional market in the United Kingdom. The HLA typing market in the United Kingdom is anticipated to deliver a market share of 69.3 million with a CAGR of 5.8% in the upcoming decade.
| Country | United Kingdom |
|---|---|
| CAGR (2018 to 2022) | 6.6% |
| CAGR (2023 to 2033) | 5.8% |
By 2023, the HLA typing industry in China is expected to experience a significant growth rate of 9.5%. The demand for HLA typing is predicted to continuously increase, with a compound annual growth rate of 7.1% over the next ten years. This growth is attributed to the improved infrastructure of healthcare facilities, expanding economic factors, and well-designed reimbursement policies, which are having a positive impact on the development of the market.
| Country | China |
|---|---|
| CAGR (2018 to 2022) | 9.5% |
| CAGR (2023 to 2033) | 7.1% |
In the upcoming years, the market for HLA typing in Japan is expected to experience significant growth. This is attributed to the development of technical and healthcare sectors in producing provinces. It is anticipated that the demand for HLA typing in Japan is likely to register a growth of 7.6% between 2023 and 2033. The healthcare sector's growing demand for HLA typing is expected to propel market growth in the next decade.
| Country | Japan |
|---|---|
| CAGR (2018 to 2022) | 9.3% |
| CAGR (2023 to 2033) | 6.5% |
The market for HLA typing in South Korea is expected to evolve rapidly in the coming years. This is due to the development of the technical and healthcare sectors in developing provinces. The demand for HLA typing in South Korea is projected to record a CAGR of around 4.7% from 2023 to 2033. The healthcare sector's increasing need for HLA typing is expected to drive market growth in the next decade.
| Country | South Korea |
|---|---|
| CAGR (2018 to 2022) | 5.2% |
| CAGR (2023 to 2033) | 4.7% |
HLA typing is increasingly essential in healthcare, providing benefits such as improved outcomes in organ transplantation, personalized medicine, better diagnosis and treatment of diseases, and scientific research opportunities. Key players in the market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, and Illumina Inc., which use organic and inorganic growth strategies to expand their consumer base.
Recent Developments in the HLA Typing Market
The HLA typing market was valued at USD 1.0 billion in 2022.
In 2023, the global HLA typing market is likely to reach USD 1.1 billion.
The HLA typing market exhibited an 8.2% CAGR over the last four years.
The market is anticipated to expand at a CAGR of 6.7% from 2023 to 2033.
The instrument products are dominating the market with a CAGR of 8.0%.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Instruments 5.2. Reagents & Consumables 5.3. Software & Services 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Diagnosis 6.2. Research 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technique 7.1. Molecular Assay 7.2. Sequenced-based Molecular Assay 7.3. Non-Molecular Assay 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user 8.1. Commercial Service Providers 8.2. Hospitals and Transplant Centers 8.3. Research Labs & Academic Institutes 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. South Asia and Pacific 9.6. East Asia 9.7. Middle East and Africa 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Key Countries Market Analysis 18. Market Structure Analysis 19. Competition Analysis 19.1. Thermo Fisher Scientific Inc. 19.2. Bio-Rad Laboratories Inc. 19.3. Qiagen N.V. 19.4. Omixon Inc. 19.5. GenDx 19.6. Illumina Inc. 19.7. TBG Diagnostics Limited 19.8. Dickinson and Company 19.9. Takara Bio Inc. 19.10. F. Hoffman-La Roche Limited 19.11. Pacific Biosciences 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
HLA Typing Market
